Application of BRAF-activated noncoding RNA (BANCR) inhibitors in a rat model of endometriosis resulted in a significant reduction in lesion size, accompanied by a decrease in mesenchymal cells and blood supply, and the BANCR inhibitors may inhibit endometriosis by inhibiting the extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK) signaling pathway to reduce the expression of molecules associated with angiogenesis (124). The gene discussed is BRAF; the disease is endometriosis.